Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

OCTREOTIDE ACETATE INJECTION 100 MCG

OCTREOTIDE (OCTREOTIDE ACETATE) : 100 MCG · DIN 02509768 · GENERIC MEDICAL PARTNERS INC

Health Canada status: APPROVED

What is OCTREOTIDE ACETATE INJECTION?

OCTREOTIDE ACETATE INJECTION 100 MCG contains OCTREOTIDE (OCTREOTIDE ACETATE) : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 02509768, held by GENERIC MEDICAL PARTNERS INC, supplied as SOLUTION for SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 17-Dec-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02509768
Brand nameOCTREOTIDE ACETATE INJECTION
Generic / active ingredientOCTREOTIDE (OCTREOTIDE ACETATE) : 100 MCG
ManufacturerGENERIC MEDICAL PARTNERS INC
Strength100 MCG
Dosage formSOLUTION
Route of administrationSUBCUTANEOUS ; INTRAVENOUS
SchedulePrescription
ATC codeH01CB02 OCTREOTIDE
AHFS class92:00.00
BiosimilarNo
Health Canada statusAPPROVED
Status date17-Dec-2020

Is OCTREOTIDE in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for OCTREOTIDE ACETATE INJECTION

What can be used instead?

Other Canadian products sharing ATC code H01CB02 OCTREOTIDE. 9 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
OCTREOTIDE ACETATE OMEGA100 MCGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02248640
OCTREOTIDE ACETATE OMEGA200 MCGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02248642
OCTREOTIDE ACETATE OMEGA50 MCGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02248639
OCTREOTIDE ACETATE OMEGA500 MCGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02248641
OCTREOTIDE INJECTION100 MCGSOLUTIONSTERIMAX INCMARKETEDDIN 02560240
OCTREOTIDE INJECTION200 MCGSOLUTIONSTERIMAX INCMARKETEDDIN 02560283
OCTREOTIDE INJECTION500 MCGSOLUTIONSTERIMAX INCMARKETEDDIN 02560291
SANDOSTATIN50 MCGSOLUTIONNOVARTIS PHARMACEUTICALS CANADA INCMARKETEDDIN 00839191
SANDOSTATIN LAR30 MGPowder For Suspension, Sustained-ReleaseNOVARTIS PHARMACEUTICALS CANADA INCMARKETEDDIN 02239325
OCPHYL100 MCGSOLUTIONPENDOPHARM DIVISION OF PHARMASCIENCE INCCANCELLED POST MARKETDIN 02413205

Who else supplies OCTREOTIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. OCTREOTIDE appears in 173 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.

Ask about availability of OCTREOTIDE ACETATE INJECTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02509768. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.